Clinical Trials Directory

Trials / Completed

CompletedNCT04589988

Aging With Long Term Physical Disabilities

Building Capacity to Improve Community Participation for People Aging With Long-Term Disability Through Evidence-Based Strategies

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
50 (actual)
Sponsor
Washington University School of Medicine · Academic / Other
Sex
All
Age
45 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine the feasibility and efficacy of an adapted evidence-based program (REBIL) to reduce barriers to community participation and remove fall hazards at home for adults aging with physical disabilities.

Detailed description

Investigators will test the working hypothesis that the adapted program, focused on resolving environmental barriers, removing fall hazards, and building self-management skills in the home and community, will be feasible and superior to usual care for daily activity performance and participation outcomes in adults aging with physical disabilities.

Conditions

Interventions

TypeNameDescription
BEHAVIORALRemoving Environmental Barriers to Independent Living (REBIL)REBIL is a complex intervention with two essential components: (1) removing environmental barriers and home hazards in the home tailored to the participant's unique abilities and limitations and (2) strategy training with the participant to help participant to be able to identify barriers in the home and community and identify potential resources and strategies to remove the barriers. Treatment includes one assessment session and four 75-minute visits in the home with an occupational therapist over 8 weeks, followed by a 6 -month assessment session by a blinded rater.
BEHAVIORALWaitlist Attentional ControlThe waitlist attentional control group will receive an initial assessment session then four 75 minute interview visits from an occupational therapy graduate assistant, followed by a 6-month assessment session by a blinded rater. After the 6-month follow-up is completed this group will receive the REBIL intervention.

Timeline

Start date
2020-11-04
Primary completion
2023-06-21
Completion
2023-06-21
First posted
2020-10-19
Last updated
2025-08-27
Results posted
2024-11-18

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04589988. Inclusion in this directory is not an endorsement.